SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-23-018039
Filing Date
2023-04-12
Accepted
2023-04-12 17:28:26
Documents
6
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 6-K brhc20051371_6k.htm 6-K 31813
2 EXHIBIT 99.2 brhc20051371_ex99-2.htm EX-99.2 126886
3 EXHIBIT 99.3 brhc20051371_ex99-3.htm EX-99.3 65694
4 EXHIBIT 99.4 brhc20051371_ex99-4.htm EX-99.4 10183
5 image00002.jpg GRAPHIC 3169
6 image00003.jpg GRAPHIC 3016
  Complete submission text file 0001140361-23-018039.txt   244434
Mailing Address 45 MESPIL ROAD DUBLIN 4 L2 D04 W2F1
Business Address DEPT 920A, 196 HIGH ROAD WOOD GREEN LONDON X0 N22 8HH 353-1-518-0200
Amryt Pharma plc (Filer) CIK: 0001783010 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39365 | Film No.: 23816554
SIC: 2834 Pharmaceutical Preparations